KLC2 and chronic myelogenous leukemia, BCR-ABL1 positive: We conducted this study to assess the functional significance of KLC2 mutations, which could help improve understanding of the disease and lead to more effective treatments for a subgroup of CML patients, as CML-CP progresses to myeloid BP.